These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37498322)

  • 1. Inclusion body myositis with early onset: a population-based study.
    Lindgren U; Hedberg-Oldfors C; Pullerits R; Lindberg C; Oldfors A
    J Neurol; 2023 Nov; 270(11):5483-5492. PubMed ID: 37498322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion-body myositis presenting with facial diplegia.
    Ghosh PS; Laughlin RS; Engel AG
    Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.
    Hedberg-Oldfors C; Lindgren U; Basu S; Visuttijai K; Lindberg C; Falkenberg M; Larsson Lekholm E; Oldfors A
    Brain Pathol; 2021 May; 31(3):e12931. PubMed ID: 33354847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic spectrum of inclusion body myositis.
    Roy B; Dimachkie MM; Naddaf E
    Clin Exp Rheumatol; 2024 Feb; 42(2):445-453. PubMed ID: 38436356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body myositis: a case of bilateral extremity weakness.
    Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK
    Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes.
    Alamr M; Pinto MV; Naddaf E
    Muscle Nerve; 2022 Dec; 66(6):686-693. PubMed ID: 36052422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis.
    Lindgren U; Pullerits R; Lindberg C; Oldfors A
    Ann Neurol; 2022 Aug; 92(2):201-212. PubMed ID: 35596584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic Inclusion Body Myositis: A Clinicopathological Study.
    Challa S; Jakati S; Narla S; Uppin MS; Kannan MA; Jagarlapudi MKM
    Neurol India; 2021; 69(3):638-641. PubMed ID: 34169859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion body myositis in twins.
    Amato AA; Shebert RT
    Neurology; 1998 Aug; 51(2):598-600. PubMed ID: 9710045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy.
    Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A
    Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings.
    Pinto MV; Laughlin RS; Klein CJ; Mandrekar J; Naddaf E
    Rheumatology (Oxford); 2022 May; 61(6):2504-2511. PubMed ID: 34617994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK; Kokkinis C; Xirou S; Chrysanthou M; Kararizou E; Papadopoulos C
    Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.
    Michelle EH; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Tiniakou E; Adler B; Mecoli CA; Danoff SK; Christopher-Stine L; Mammen AL; Lloyd TE
    Neurology; 2023 Mar; 100(13):e1406-e1417. PubMed ID: 36690456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of sporadic inclusion body myositis.
    Molberg Ø; Dobloug C
    Curr Opin Rheumatol; 2016 Nov; 28(6):657-60. PubMed ID: 27541181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial pathology in inclusion body myositis.
    Lindgren U; Roos S; Hedberg Oldfors C; Moslemi AR; Lindberg C; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):281-8. PubMed ID: 25638290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.
    Joshi PR; Vetterke M; Hauburger A; Tacik P; Stoltenburg G; Hanisch F
    J Clin Neurosci; 2014 Nov; 21(11):1959-63. PubMed ID: 25311418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature.
    Chatterjee S; Prayson RA
    Semin Arthritis Rheum; 2020 Jun; 50(3):498-502. PubMed ID: 31806155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.